跳至主要内容
临床试验/CTRI/2022/03/041516
CTRI/2022/03/041516已完成未知

A multi-centric, cross-sectional, observational study of pregnancy test kit for rapid detection of pregnancy in subjects scheduled for detection of Pregnancy.

Mankind Pharma Limited Mankind Pharma Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Healthy female subjects of child-bearing age group of ââ?°Â¥18 to ââ?°Â¤50 years.
  • 2. Who either request a pregnancy test, or require a pregnancy test for diagnostic studies or treatment.
  • 3. Written informed consent from the subject, legally acceptable representative or parent and able to follow study procedures.

排除标准

  • Subjects who are not able to or not willing to sign an IRB/IEC approved consent form.
  • 2. Known pregnancy.
  • 3. Symptomatic COVID-19 suspected subjects (as assessed by the COVID-19 Questionnaire).
  • 4. Hemodynamically unstable.
  • 5. Moderately to severely ill-appearing or in moderate to severe pain.
  • 6. Technically not possible to obtain blood from the study subject.

研究者

发起方
Mankind Pharma Limited Mankind Pharma Limited

相似试验

Observational study of pregnancy kit for rapid... | 临床试验